Abstract:Pleural mesothelioma is an uncommon malignancy that is rarely amenable to definitive resection. Local and regional recurrence are common and the median overall survival is approximately 1 year (1). Therefore, multimodality therapy employing systemic therapies before or after resection, usually with radiotherapy as well, has been evaluated in attempts to improve outcome. The purpose of this review is to discuss issues in induction and adjuvant therapy including the drugs, issues in trial design and evaluation, … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.